ArticleFrontiers in medicine2021

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19.

Helena Enocsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.